This page shows the latest tuberculosis news and features for those working in and with pharma, biotech and healthcare.
The BCG vaccine, originally developed in 1921, is traditionally used to protect against tuberculosis although it is no longer routinely administered in the UK.
That included showing efficacy against tuberculosis and strains of bacteria which are considered untreatable or resistant to currently approved antibiotics.
Vaccine has demonstrated around 50% efficacy in preventing disease. GlaxoSmithKline is out in front among efforts to develop a new vaccine against tuberculosis, but has decided it won’t take the
Certain infections, such as pneumonia, tuberculosis, blood poisoning, gonorrhoea and others are becoming resistant to standard antibiotics, making them increasingly hard-to-treat.
In addition to identifying these new drug shortages, the document also revealed ongoing issues with 69 different types and doses of medication including antibiotics for tuberculosis, diamorphine, various cancer drugs, heart
GlaxoSmithKline has announced that its IAVI-partnered experimental tuberculosis (TB) vaccine candidate significantly reduced the occurrence of pulmonary tuberculosis disease. . ... These final results show that M72/AS01E could be an important tool in
More from news
Approximately 19 fully matching, plus 112 partially matching documents found.
BCG, widely used for childhood immunisation against tuberculosis, has been particularly affected due to experimental use as a treatment for COVID-19.
Tuberculosis and Malaria.
An FDA study found that at least three WHOdesignated ‘essential medicines’ are made from APIs sourced only in China: capreomycin and streptomycin, both used to treat tuberculosis; and sulfadiazine, used to
In September 2010 he joined Aeras, a non-profit Product Development Partnership with a mission to develop global tuberculosis vaccines, as the Chief Scientific Officer, and became CEO in February 2013.
Combination therapy. Antibiotic Combination Therapy was developed in 1952 for the treatment of tuberculosis. ... Combination therapy is the norm in the treatment of many cancers and viral infections such as HIV and even some bacterial diseases such as
More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.
In total Dr Pomerantz has been involved with the development of eight approved drugs for infectious diseases, covering HIV, hepatitis C and tuberculosis.
He currently serves on the boards of several biotechnology companies including Aeras, an organisation dedicated to the development of tuberculosis vaccines.
Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark Dybul as executive director.
More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.
The impact. An increasing number of common infections such as pneumonia, tuberculosis, gonorrhoea and salmonellosis are becoming harder to treat as antibiotics become less effective. ... The global statistics. 123 countries report extensive multi-drug
2. Characterised by very low levels of CD4+ T cells, and the presence of AIDS-related pathologies (such as tuberculosis and Kaposi’s sarcoma), the diagnosis of AIDS marks just how
Doctors noticed that tuberculosis patients treated with isoniazid showed signs of improved mood.
due to migration to the urban centres of the west. In Eastern Turkey, outbreaks of communicable diseases such as tuberculosis are still occurring. Pharma investment therefore remains focused on the western
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...